Human papillomavirus vaccination: the population impact

Area of Science:

• Public Health
• Vaccinology
• Preventive Medicine

Background:

• Human papillomavirus (HPV) causes significant global disease burden.
• Prophylactic HPV vaccination programs are established public health initiatives.
• HPV-based screening offers improved cervical abnormality detection compared to cytology.

Purpose of the Study:

• To describe the impact of prophylactic HPV vaccination on HPV-related disease outcomes.
• To highlight the shift towards HPV-based screening in cervical cancer prevention.
• To advocate for universal access to HPV vaccination and screening.

Main Methods:

• Review of real-world data from countries with implemented HPV vaccination programs.
• Analysis of the effectiveness of HPV-based screening in cervical abnormality detection.
• Assessment of the benefits of gender-neutral HPV vaccination strategies.

Main Results:

• Observed reductions in HPV infections, genital warts, and cervical pre-cancers in vaccinated populations.
• Growing evidence supporting HPV-based screening as a more sensitive detection method.
• Emerging adoption of gender-neutral vaccination in some countries.

Conclusions:

• HPV vaccination and screening are critical tools for preventing HPV-related diseases.
• Global initiatives aim to ensure universal access to prevention and screening.
• Gender-neutral vaccination and comprehensive national programs are recommended for broader protection.